What is Othram?
Othram operates as the world's first private DNA laboratory purpose-built for forensic evidence analysis. Leveraging modern parallel sequencing, the company specializes in recovering and analyzing human DNA from minute, degraded, or contaminated samples. Founded in 2018 and based in The Woodlands, Texas, Othram collaborates with academic researchers, forensic scientists, medical examiners, and law enforcement agencies. Their expertise is crucial in achieving DNA analysis results when conventional methods fall short, providing vital insights for investigations and justice.
How much funding has Othram raised?
Othram has raised a total of $18.1M across 2 funding rounds:
Debt
$150K
Angel/Seed
$18M
Debt (2020): $150K with participation from PPP
Angel/Seed (2021): $18M led by Gigafund 0
Key Investors in Othram
Gigafund 0
Gigafund is a venture capital firm that invests in ambitious and transformative entrepreneurs across various sectors and stages. The firm focuses on long-term concentrated investments, seeking founders who can grow with their companies and maximize impact over decades. Gigafund's portfolio includes notable companies like SpaceX, Neuralink, and The Boring Company, reflecting its commitment to backing significant businesses that aim to solve the world's biggest problems. By prioritizing a long-term investment strategy, Gigafund aims to identify and support companies that will become transformative leaders in their industries.
PPP
Public-Private Partnership
What's next for Othram?
With its recent major strategic investment, Othram is poised to further enhance its capabilities in forensic DNA analysis. This capital infusion is expected to fuel advancements in their proprietary sequencing technologies and expand their laboratory infrastructure. The company's focus on tackling challenging DNA samples suggests a strategic direction towards broadening its service offerings to more complex cases and potentially developing new analytical tools. Continued growth in this specialized sector indicates a strong market demand for Othram's unique scientific contributions.
See full Othram company page
